Contraception
Label comprehension study for a proposed over-the-counter progestin-only pill.
Kate Grindlay, Russell D Bradford, Sabrina Pradeau, Hélène Guillard, Irene Laurora
Published: 202510.1016/j.contraception.2025.111360
Abstract
OBJECTIVE: As part of an over-the-counter switch application to the US Food and Drug Administration for a norgestrel 0.075 mg progestin-only pill (Opill), we aimed to determine if key messages from the proposed Drug Facts Label were adequately unders…
Preview only. Read the full abstract at the source